MedPath

济南永宁制药股份有限公司

Ownership
-
Established
1993-03-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

159

NMPA:159

Drug Approvals

Compound Bergenine Tablets

Product Name
复方岩白菜素片
Approval Number
国药准字H37020693
Approval Date
Nov 9, 2022
NMPA

Chlordiazepoxide Tablets

Product Name
氯氮䓬片
Approval Number
国药准字H37022535
Approval Date
Nov 2, 2022
NMPA

Licorzine Capsules

Product Name
甘草锌胶囊
Approval Number
国药准字H37023236
Approval Date
Nov 2, 2022
NMPA

Chlordiazepoxide Tablets

Product Name
氯氮䓬片
Approval Number
国药准字H37022536
Approval Date
Nov 2, 2022
NMPA

Triamterene Tablets

Product Name
氨苯蝶啶片
Approval Number
国药准字H37022544
Approval Date
Nov 2, 2022
NMPA

Diazepam Tablets

Product Name
地西泮片
Approval Number
国药准字H37020393
Approval Date
Nov 2, 2022
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H37020163
Approval Date
Nov 2, 2022
NMPA

Estazolam Tablets

Product Name
艾司唑仑片
Approval Number
国药准字H37020697
Approval Date
Nov 2, 2022
NMPA

Clonazepam Tablets

Product Name
氯硝西泮片
Approval Number
国药准字H37020391
Approval Date
Nov 2, 2022
NMPA

Fosfomycin Calcium Capsules

Product Name
磷霉素钙胶囊
Approval Number
国药准字H37023648
Approval Date
Aug 13, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.